Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 15 of 35

TERMINATED Phase 1

Investigation of Mechanisms of Action in Superpower Glass

NCT04049981

COMPLETED Phase 2

Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

NCT04008069

TERMINATED Phase 2

The Role of Secondary Bile Acids in Intestinal Inflammation

NCT03724175

COMPLETED Phase 4

Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery

NCT03861988

COMPLETED

Stanford Regulating Circuits of the Brain Study- Ketamine

NCT03475277

COMPLETED NA

A Novel fNIRS Neurofeedback Intervention for Enhancement of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD)

NCT04002167

COMPLETED NA

Question Prompt List for Orthopaedic Conditions

NCT03912168

COMPLETED Phase 1

Sickness Evaluation at Altitude With Acetazolamide at Relative Doses

NCT03828474

COMPLETED Phase 2

Postoperative Pain Management in Rhinoplasty

NCT03584152

COMPLETED

Effect of Night Float Call on Sleep and Activity Patterns Among Anesthesia Residents

NCT05043038

COMPLETED NA

Feasibility Study Comparing Standard FBT and Guided Self-Help FBT for Adolescent Anorexia Nervosa

NCT04957498

TERMINATED NA

Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

NCT03844646

TERMINATED NA

Study to Intervene With Nutrition for Gastroparesis

NCT03987672

TERMINATED NA

Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD

NCT04313985

COMPLETED NA

Physical Therapy Using Virtual Reality/Augmented Reality

NCT03874507

COMPLETED NA

Ice Immersion Using Virtual Reality & Augmented Reality

NCT04196686

TERMINATED Phase 2

Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

NCT03988647

COMPLETED Phase 1

Retinal Effects of Balance Goggles System in Glaucoma Balance Goggles System (BGS) in Patients With Glaucoma

NCT04035239

COMPLETED

Complement C5a Receptors in Hidradenitis Suppurativa

NCT04251663

COMPLETED NA

Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation

NCT03659734

COMPLETED NA

Lap-assisted vs. US-Guided Visualization of TAP Blocks

NCT04226300

COMPLETED NA

Virtual Reality vs Inperson Simulation: A Non-inferiority Study

NCT03863314

COMPLETED NA

Pilot Accelerated Theta Burst in Treatment-Resistant Bipolar Depression

NCT03953417

TERMINATED

Characterization of Treatment Responses in Lymphedema

NCT03783715

COMPLETED NA

Tweet4Wellness: An Online Virtual Support Group for Promoting Increased Physical Activity

NCT02958189

COMPLETED Early Phase 1

Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder

NCT05463822

COMPLETED NA

Effects of a Compliant Arm Support on Post-stroke Upper Extremity Range of Motion

NCT03867838

COMPLETED NA

Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery

NCT03807505

COMPLETED NA

Regional Anesthesia for Cardiothoracic Enhanced Recovery (RACER) Study

NCT03611374

COMPLETED NA

Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial

NCT03810378

COMPLETED NA

Passive Tactile Stimulation for Stroke Rehabilitation

NCT03814889

COMPLETED Phase 2

Cardiac Allograft Vasculopathy Inhibition With Alirocumab

NCT03537742

COMPLETED

Characterizing the Association Between Preoperative Depressive Symptoms and Opioid Use/Misuse After Surgery

NCT05412342

COMPLETED NA

Effects of a Platelet Transfusion Best Practices Alert

NCT04155775

COMPLETED NA

TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources

NCT04018677

COMPLETED NA

Electronic Record Assimilation and Subsequent Eradication of Hepatitis C

NCT04873609

COMPLETED NA

Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation

NCT03958903

COMPLETED NA

Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer

NCT03832686

COMPLETED NA

GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity

NCT03620071

COMPLETED Phase 2

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

NCT03836001

COMPLETED Early Phase 1

Ulipristal Acetate for Cervical Preparation

NCT03802149

TERMINATED

Recovery of Ventilation After General Anesthesia in Morbidly Obese Patients

NCT03925610

TERMINATED Phase 2

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

NCT03912818

COMPLETED NA

Question Prompt List for Common Hand Conditions

NCT03868449

COMPLETED Phase 4

Pain Control Following Sinus Surgery

NCT03783702

COMPLETED NA

Coaches Activating Reaching and Engaging Patients

NCT03856463

COMPLETED

Distributed Registry

NCT03898570

COMPLETED NA

Feasibility and Efficacy of a Digital Mental Health Intervention for Teen Wildfire Survivors

NCT03868761

TERMINATED NA

Establishing Functional Biomarkers for Spaced Theta-Burst Stimulation

NCT03687892

TERMINATED NA

Trigger Finger Preference Elicitation Tool

NCT03909490

← Previous Page 15 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.